Regular Article| Volume 88, ISSUE 2, P150-154, February 2000

Download started.


Evaluation of the Role of Intercellular Adhesion Molecule 1 in a Rodent Model of Chronic Venous Hypertension

      This paper is only available as a PDF. To read, Please Download here.


      Purpose. To evaluate the role of intercellular adhesion molecule 1 (ICAM-1) in cutaneous leukocyte trapping in venous disease, we used our rodent model of venous hypertension (VH).
      Materials and methods. VH was created in adult rats by ligation of the inferior vena cava, bilateral common iliac veins, and bilateral common femoral veins. In the Phase I experimental (exptl) group, anti-ICAM-1 monoclonal antibody (1A29) was given intravenously prior to venous ligations. Acute venous pressures were measured in the exptl and control (ctrl) (ligation only) groups. Bilateral forelimb and hindlimb skin specimens were harvested for myeloperoxidase (MPO) assay. In Phase II, VH was created in a chronic group; in a sham-operated group, ties were placed around the same vessels without ligations. Two weeks later, venous pressures were measured and radiolabeled (125I and 131I) monoclonal antibody (mAb) to ICAM-1 was injected and allowed to circulate for 5 min before the level of radiolabeled antibody within forelimb and hindlimb specimens was measured.
      Results. In the acute study with 1A29, hindlimb pressures were significantly elevated in both the ctrl (n = 4) and exptl (n = 4) hindlimbs (15.4 ± 0.239 and 13.8 ± 1.89 mm Hg, respectively) compared with ctrl and exptl forelimbs (1.38 ± 0.554 and 1.50 ± 0.612 mm Hg, respectively). However, MPO activity was significantly elevated in the hindlimbs of the ctrl group compared with the hindlimbs of the exptl animals (19.8 ± 1.54 U vs 6.71 ± 2.46 U). In the chronic VH rats (n = 5) given radiolabeled anti-ICAM-1 mAb, the hindlimb pressures (10.1 ± 4.52 mm Hg) were significantly elevated (P < 0.05) compared with forelimb pressures (1 ± 0.447 mm Hg) and compared with the forelimb and hindlimb pressures in the sham-operated animals (n = 4) (1.63 ± 0.813 and 4.25 ± 2.13 mm Hg, respectively). However, there was not a significant difference in the quantity of ICAM-1—hindlimb versus forelimb or chronic VH versus sham.
      Conclusions. Anti-ICAM-1 mAb decreased MPO activity in hypertensive hindlimb skin, supporting the instrumental role of ICAM-1 in cutaneous leukocyte trapping. However, the constituent endothelial ICAM-1 is not elevated by VH.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Surgical Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect



        • Lalka S.
        • Unthank J.
        Operative management of lower extremity venous insufficiency.
        in: Strandness Jr., D.D. Van Breda A. Vascular Disease: Surgical and Interventional Therapy. Churchill Livingstone, New York1994: 983-998
        • Christopoulos D.C.
        • Belcaro G.
        • Nicolaides A.N.
        The hemodynamic effect of venous hypertension in the microcirculation of the lower limb.
        J. Cardiovasc. Surg. 1995; 36: 403
        • Rutherford R.
        Venous surgery and the need for critical appraisal.
        Semin. Vasc. Surg. 1988; 1: 57
        • Browse N.
        • Burnand K.
        • Thomas M.
        The calf pump failure syndrome: Diagnosis and treatment.
        Diseases of the Veins: Pathology, Diagnosis and Treatment. Edward Arnold, London1988 (p. 335–348)
        • Wilkinson L.
        • Bunker M.
        • Edwards J.
        • Scurr J.
        Leukocytes: Their role in the etiopathogenesis of skin damage in venous disease.
        J. Vasc. Surg. 1993; 17: 669
        • Coleridge Smith P.
        • Thomas P.
        • Scurr J.
        • Dormandy J.
        Causes of venous ulcerations: A new hypothesis.
        Br. Med. J. 1988; 296: 1726
        • Cheatle T.
        • Sarin S.
        • Coleridge Smith P.
        • Scurr J.
        The pathogenesis of skin damage in venous disease: A review.
        Eur. J. Vasc. Surg. 1991; 5: 115
        • Coleridge Smith P.
        • Scurr J.
        Current views on the pathogenesis of venous ulceration.
        in: Bergan J. Yao J. Venous Disorders. Saunders, Philadelphia1991: 46-51
        • Moyses C.
        • Cederholm-Williams S.
        • Michel C.
        Haemonconcentration and accumulation of white cells in the feet during venous stasis.
        Int. J. Microcirc. Clin. Exp. 1987; 5: 311
        • Thomas P.
        • Nash G.
        • Dormandy J.
        White cell accumulation in dependent legs of patients with venous hypertension: A possible mechanism for trophic changes in the skin.
        Br. Med. J. 1988; 296: 1693
        • Lalka S.
        • Unthank J.
        • Nixon J.
        Elevated cutaneous leukocyte concentration in a rodent model of acute venous hypertension.
        J. Surg. Res. 1988; 74: 59
        • Hahn T.L.
        • Unthank J.L.
        • Lalka S.G.
        Increased hindlimb leukocyte concentration in a chronic rodent model of venous hypertension.
        J. Surg. Res. 1999; 74: 38
        • Sahary M.
        • Shields D.A.
        • Georgiannos S.N.
        • Porter J.B.
        • Scurr J.H.
        • Coleridge Smith P.D.
        Endothelial activation in patients with chronic venous disease.
        Eur. J. Vasc. Endovasc. Surg. 1998; 15: 342
        • Arndt H.
        • Smith C.
        • Granger D.
        Leukocyte–endothelial cell adhesion in spontaneously hypertensive and normotensive rats.
        Hypertension. 1993; 21: 667
        • Granger D.
        • Zimmerman B.
        • Skeizuka E.
        • Grisham M.
        Intestinal microvascular exchange in the rat during luminal perfusion with formyl-methionyl-leucyl-phenylalanine.
        Gastroenterology. 1988; 94: 673
        • Eppihimer M.J.
        • Granger D.N.
        In vivo measurements of endothelial cell adhesion molecule expression.
        Methods Enzymol. 1998; 301: 14
        • Ettenson D.S.
        • Gotleib A.I.
        Endothelial repair.
        Can. Med. Assoc. J. 1990; 142: 601
        • Gibbous G.H.
        • Dzaa V.J.
        The emerging concept of vascular remodeling.
        N. Engl. J. Med. 1994; 330: 1431
        • Cassada D.C.
        • Reeves T.R.
        Adhesion molecules and vascular disease.
        Contemp. Surg. 1998; 52: 193
        • Rothlein R.
        • Mainolfi E.A.
        • Czajkowski M.
        • Marlin S.D.
        A form of circulating ICAM-1 in human serum.
        J. Immunol. 1991; 147: 3788
        • Edelman G.M.
        • Crossin K.L.
        Cell adhesion molecules.
        Annu. Rev. Biochem. 1991; 60: 155
        • Bevilacqua M.P.
        • Pober J.S.
        • Mendrick D.L.
        • Cotran R.S.
        • Gimbrone Jr., M.A.
        Identification of an inducible endothelial–leukocyte adhesion molecule.
        Proc. Natl. Acad. Sci. USA. 1987; 84: 9238
        • Marlin S.D.
        • Springer T.A.
        Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1).
        Cell. 1987; 51: 813
        • Banks R.E.
        • Gearing A.J.
        • Hemingway I.K.
        • Norfolk D.R.
        • Perren T.J.
        • Selby P.J.
        Circulating intercellular adhesion moleucle-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies.
        Br. J. Cancer. 1993; 68: 122